Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic. by unknown
Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by the Severe Acute 
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The disease is characterized by a respiratory 
infection with symptoms ranging from mild common cold/flu-like to more serious health problems. The 
symptoms usually include fever, coughing, sore throat and shortness of breath. Muscle pain and 
tiredness have also been described. 
On 11 March 2020, the World Health Organization (WHO) announced that the current outbreak of 
COVID-19 is a pandemic1. Although COVID-19 is usually mild and most people recover quickly, it can 
be very serious for certain groups of people, including the elderly and people with stressed 
immune systems or underlying conditions. 
Pandemics and health emergencies like the current COVID-19 outbreak can cost many lives and pose 
additional risks to the global economy and overall security and stability. Ensuring continued access 
to health care during a pandemic, including services for people who use drugs and treatment of drug 
use disorders, is key not only to protect the health of populations, but also key to security and stability.  
Drug use disorders are frequently accompanied by somatic conditions such as HIV/AIDS, hepatitis B 
and/or C, tuberculosis, lung or cardiovascular disease, stroke, cancer and injuries and traumas 
among others. Moreover, people with drug use disorders, especially those who inject drugs, may 
have a compromised immune system. Finally, stigma and discrimination linked to drug use and drug 
use disorders often result in limited access to basic resources such as housing, employment, health 
care and social support. For all these reasons, it may be more difficult for people who use drugs and 
with drug use disorders to protect themselves and they may be particularly at risk of developing 
COVID-19. 
Therefore, it is important to ensure the continuity of adequate access to health and social services 
for people who use drugs and with drug use disorders and to provide the continuum of care required as 
described in the International Standards for the Treatment of Drug Use Disorders (UNODC/WHO, 
2020) to the best extent possible also in times of crisis. This includes low-threshold services as well as 
psychosocial treatment and pharmacological treatment in a range of settings.
This is also in line with the strong mandates of the Member States of the United Nations that have, 
inter alia, committed to health for all leaving no one behind in the 2030 agenda and highlighted the 
need to protect the health, safety and well-being of individuals, families, vulnerable members of society, 
communities and society as a whole in the UNGASS 2016 Outcome Document on addressing the 
world drug problems. 
In this context, it is suggested that Member States and drug treatment, care and rehabilitation systems 
and services develop plans to ensure continuity of care for people who use drugs and people 
with drug use disorders, bearing in mind the following issues. 
Address the safety of the staff and 
the patients at the services 
Consider the need to organize the delivery of 
services so that the risks associated with close 
contact with people or any other form of social 
gathering are minimized; for example, waiting 
rooms and queues in outpatient settings might 
need to be reorganized, whilst in residential 
settings, measures to reduce the spread of the 
virus amongst people already in treatment, 
whilst ensuring continuity of care will need to 
be applied. Train staff, including outreach 
workers, on COVID-19 prevention and provide 
them with protection equipment.
Address continued access to 
the services
Consider the continued access of people to 
the services even and especially in times of 
crisis; prepare service continuation plans, 
make sure overall recommendations for 
infectious respiratory diseases are followed 
and special guidelines for COVID-19 patients 
are in place. 
COVID-19
Provide people with information on 
and means to protect themselves at every 
possible occasion
Refer to WHO guidance to provide information to people 
about how to protect themselves and provide people in 
contact with the services with basic hygienic necessities 
to protect themselves from the virus, such as soap2. 
Encourage people not to gather together to the extent 
possible, highlighting dangers for themselves and others. 
Brief staff and people in contact with the services that, 
if COVID-19 starts spreading in their community, anyone 
with even a mild cough or low-grade fever (37.3 C or more) 
needs to stay at home. 
Make sure the premises of the services are 
clean and hygienic
Refer to WHO guidance including: surfaces and objects 
wiped with disinfectant regularly; regular and thorough 
hand-washing by staff and people that visit the services 
promoted; sanitizing hand rub dispensers are made available 
in prominent places around the premises; dispensers are 
regularly refilled; posters promoting hand-washing are 
displayed; ensuring that that staff and people visiting the 
services have access to places where they can wash their 
hands with soap and water. 
Whilst hard, crisis times, like the current pandemic, are another chance to recall universal human values and unite our forces to work together for the same goal, leaving no one behind, including 
people who use drugs, with drug use disorders and their families. 
Continuity of psycho-social therapies
If therapies, including group therapy, need 
or will need to be suspended, consider the 
possibility of providing contact remotely3 
(e.g. by phone or internet)4,5 and/or on an 
individual basis to provide patients with 
the care and support required.
Under no condition should a person be 
denied access to health care based on the 
fact that they use drugs! 
Ensure access to respiratory assistance, including intensive 
care when required, to people who use drugs and with drug 
use disorders without discrimination. Consider the fact that 
people with drug use disorders who are not yet in treatment, 
might be interested to start in this time of crisis: it is crucial 
to be ready to provide support as soon as possible. For this 
purpose, drug treatment centers can establish separate 
triage services to address COVID-19 related queries and 
drug treatment demand without delays.
Support homeless people, including people 
with drug use disorders
Provide shelter keeping in mind social distancing guidance, 
as possible; distribute safety and hygiene equipment when 
possible and ensure access to the basic WHO recommended 
prevention measures.
Continuity of pharmacological therapy
Consider measures for continued access of all medications, including: restocking, providing delivery at home, take-home 
medication, extended prescriptions, and extended-release formulations.
 • Naloxone needs to be available on premises and provided to people who use opioids and/or those likely to witness 
  an opioid overdose. 
 • With regard to opioid agonist maintenance therapy with methadone and buprenorphine (including extended release 
  buprenorphine where available), increase the number of patients which are eligible for take-home doses, providing   
  take-home doses for a minimum of two weeks; pre-prepare the doses for each patient to reduce the waiting time; 
  and schedule the pick-up times so that the daily number of patients accessing the services is low. 
 • If withdrawal is a concern, ensure people have access to supportive medication.
 • Consider continued access to symptomatic medications and medication for the treatment of co-occurring disorders.
 • For some highly motivated people with opioid use disorders or in places where maintenance treatment with opioid 
  agonists is not available, access to naltrexone for relapse prevention might be an option.
A contribution to the health security of countries and communities
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Continuity of low-threshold services
Distribute naloxone to people likely to witness 
an opioid overdose including those who use 
opioids, outreach workers, and first responders 
for emergency responses to opioid overdose; 
maximize efforts to distribute clean needles 
to people who inject drugs to avoid sharing 
of needles; consider the continuation of peer 
support even through remote means of 
communication.
1 https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
2  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
3  https://www.unodc.org/documents/17-01904_Rural_treatment_ebook.pdf
4 https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet
5  https://www.unodc.org/documents/17-01904_Rural_treatment_ebook.pdf
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A contribution to the health security of countries and communities
Coronavirus disease 2019 (COVID-19) is a 
respiratory illness caused by the Severe Acute 
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
The disease is characterized by a respiratory 
infection with symptoms ranging from mild 
common cold/flu-like to more serious health problems. 
The symptoms usually include fever, coughing, 
sore throat and shortness of breath. Muscle pain 
and tiredness have also been described. 
On 11 March 2020, the World Health Organization 
(WHO) announced that the current outbreak of 
COVID-19 is a pandemic1. Although COVID-19 is 
usually mild and most people recover quickly, it 
can be very serious for certain groups of 
people, including the elderly and people with 
stressed immune systems or underlying conditions. 
Pandemics and health emergencies like the 
current COVID-19 outbreak can cost many lives 
and pose additional risks to the global economy 
and overall security and stability. Ensuring continued 
access to health care during a pandemic, including 
services for people who use drugs and treatment 
of drug use disorders, is key not only to protect the 
health of populations, but also key to security 
and stability.  
Drug use disorders are frequently accompanied 
by somatic conditions such as HIV/AIDS, hepatitis 
B and/or C, tuberculosis, lung or cardiovascular 
disease, stroke, cancer and injuries and traumas 
among others. Moreover, people with drug use 
disorders, especially those who inject drugs, may 
have a compromised immune system. Finally, 
stigma and discrimination linked to drug use and 
drug use disorders often result in limited access to 
basic resources such as housing, employment, 
health care and social support. For all these 
reasons, it may be more difficult for people who 
use drugs and with drug use disorders to protect 
themselves and they may be particularly at risk 
of developing COVID-19. 
Therefore, it is important to ensure the continuity 
of adequate access to health and social services 
for people who use drugs and with drug use 
disorders and to provide the continuum of care 
required as described in the International 
Standards for the Treatment of Drug Use 
Disorders (UNODC/WHO, 2020) to the best extent 
possible also in times of crisis. This includes 
low-threshold services as well as psychosocial 
treatment and pharmacological treatment in a 
range of settings.
This is also in line with the strong mandates of the 
Member States of the United Nations that have, 
inter alia, committed to health for all leaving no 
one behind in the 2030 agenda and highlighted 
the need to protect the health, safety and well-being 
of individuals, families, vulnerable members of 
society, communities and society as a whole in the 
UNGASS 2016 Outcome Document on addressing 
the world drug problems. 
In this context, it is suggested that Member States 
and drug treatment, care and rehabilitation 
systems and services develop plans to ensure 
continuity of care for people who use drugs 
and people with drug use disorders, bearing in 
mind the following issues. 
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Address the safety of the staff and the 
patients at the services 
Consider the need to organize the delivery of services so that the 
risks associated with close contact with people or any other form of 
social gathering are minimized; for example, waiting rooms and 
queues in outpatient settings might need to be reorganized, whilst 
in residential settings, measures to reduce the spread of the virus 
amongst people already in treatment, whilst ensuring continuity of 
care will need to be applied. Train staff, including outreach workers, 
on COVID-19 prevention and provide them with protection equipment.
Address continued access to the services
Consider the continued access of people to the services even and 
especially in times of crisis; prepare service continuation plans, 
make sure overall recommendations for infectious respiratory 
diseases are followed and special guidelines for COVID-19 
patients are in place. 
COVID-19
Make sure the premises of the services 
are clean and hygienic
Refer to WHO guidance including: surfaces and objects wiped with 
disinfectant regularly; regular and thorough hand-washing by staff 
and people that visit the services promoted; sanitizing hand rub 
dispensers are made available in prominent places around the 
premises; dispensers are regularly refilled; posters promoting 
hand-washing are displayed; ensuring that that staff and people 
visiting the services have access to places where they can wash 
their hands with soap and water. 
Provide people with information on and 
means to protect themselves at every 
possible occasion
Refer to WHO guidance to provide information to people about 
how to protect themselves and provide people in contact with the 
services with basic hygienic necessities to protect themselves 
from the virus, such as soap2. Encourage people not to gather 
together to the extent possible, highlighting dangers for them-
selves and others. Brief staff and people in contact with the 
services that, if COVID-19 starts spreading in their community, 
anyone with even a mild cough or low-grade fever (37.3 C or 
more) needs to stay at home. 
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Continuity of pharmacological therapy
Consider measures for continued access of all medications, including: 
restocking, providing delivery at home, take-home medication, 
extended prescriptions, and extended-release formulations.
 • Naloxone needs to be available on premises and provided to  
  people who use opioids and/or those likely to witness an  
  opioid overdose. 
    
 • With regard to opioid agonist maintenance therapy with  
  metha done and buprenorphine (including extended release  
  buprenorphine where available), increase the number of 
  patients which are eligible for take-home doses, providing  
  take-home doses for a minimum of two weeks; pre-prepare  
  the doses for each patient to reduce the waiting time; and  
  schedule the pick-up times so that the daily number of  
  patients accessing the services is low. 
  
 • If withdrawal is a concern, ensure people have access to  
  supportive medication.
 • Consider continued access to symptomatic medications and  
  medication for the treatment of co-occurring disorders.
 • For some highly motivated people with opioid use disorders  
  or in places where maintenance treatment with opioid agonists
   is not available, access to naltrexone for relapse prevention  
  might be an option.
Continuity of low-threshold services
Distribute naloxone to people likely to witness an opioid overdose 
including those who use opioids, outreach workers, and first 
responders for emergency responses to opioid overdose;
maximize efforts to distribute clean needles to people who inject 
drugs to avoid sharing of needles; consider the continuation of 
peer support even through remote means of communication.
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Whilst hard, crisis times, like the current pandemic, are another chance to recall 
universal human values and unite our forces to work together for the same goal, 
leaving no one behind, including people who use drugs, with drug use disorders 
and their families. 
Continuity of psycho-social therapies
If therapies, including group therapy, need or will need to be 
suspended, consider the possibility of providing contact remotely3 
(e.g. by phone or internet)4,5 and/or on an individual basis to 
provide patients with the care and support required.
Under no condition should a person be 
denied access to health care based on 
the fact that they use drugs! 
Ensure access to respiratory assistance, including intensive 
care when required, to people who use drugs and with drug use 
disorders without discrimination. Consider the fact that people 
with drug use disorders who are not yet in treatment, might be inter-
ested to start in this time of crisis: it is crucial to be ready to 
provide support as soon as possible. For this purpose, drug 
treatment centers can establish separate triage services to 
address COVID-19 related queries and drug treatment demand 
without delays.
Support homeless people, including 
people with drug use disorders
Provide shelter keeping in mind social distancing guidance, 
as possible; distribute safety and hygiene equipment when 
possible and ensure access to the basic WHO recommended 
prevention measures.
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